{"id":"https://openalex.org/W4411291015","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17","title":"Abstract P2-11-17: Atezolizumab in combination w/ polychemotherapy w/ or without a pretherapeutic immune therapy window in patients w/ early triple negative breast cancer (eTNBC) & low tumor burden \u2013 prospective data from the randomized neoadjuvant neoMono trial","display_name":"Abstract P2-11-17: Atezolizumab in combination w/ polychemotherapy w/ or without a pretherapeutic immune therapy window in patients w/ early triple negative breast cancer (eTNBC) & low tumor burden \u2013 prospective data from the randomized neoadjuvant neoMono trial","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411291015","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-p2-11-17","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026211073","display_name":"Cornelia Kolberg\u2010Liedtke","orcid":"https://orcid.org/0000-0003-4526-3368","observed_orcids":["https://orcid.org/0000-0003-4526-3368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cornelia Kolberg-Liedtke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Johannes Schumacher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Schumacher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089383800","display_name":"Ramona Erber","orcid":"https://orcid.org/0000-0003-0315-1229","observed_orcids":["https://orcid.org/0000-0003-0315-1229"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramona Erber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053751196","display_name":"Michael Braun","orcid":"https://orcid.org/0000-0002-6666-4868","observed_orcids":["https://orcid.org/0000-0002-6666-4868","https://orcid.org/0000-0002-5083-6688"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Braun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017728105","display_name":"Peter Andreas Fasching","orcid":"https://orcid.org/0000-0003-4885-8471","observed_orcids":["https://orcid.org/0000-0003-4885-8471","https://orcid.org/0000-0003-1709-1079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter A. Fasching","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013148496","display_name":"Eva\u2010Maria Grischke","orcid":"https://orcid.org/0000-0001-7413-5053","observed_orcids":["https://orcid.org/0000-0001-7413-5053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva-Maria Grischke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032626301","display_name":"Christian Schem","orcid":"https://orcid.org/0000-0001-8606-3077","observed_orcids":["https://orcid.org/0000-0001-8606-3077"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Schem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009308924","display_name":"Michael P. Lux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael P. Lux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023727769","display_name":"Mustafa Deryal","orcid":"https://orcid.org/0009-0001-4634-2378","observed_orcids":["https://orcid.org/0009-0001-4634-2378"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustafa Deryal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009730025","display_name":"Oliver Ingo Hoffmann","orcid":"https://orcid.org/0000-0002-4624-9755","observed_orcids":["https://orcid.org/0000-0002-4624-9755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Hoffmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110745684","display_name":"Bernhard Heinrich","orcid":"https://orcid.org/0000-0002-9334-1335","observed_orcids":["https://orcid.org/0000-0002-9334-1335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernhard Heinrich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007647646","display_name":"Georg Kunz","orcid":"https://orcid.org/0009-0006-4081-1176","observed_orcids":["https://orcid.org/0009-0006-4081-1176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georg Kunz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047866167","display_name":"Kristina L\u00fcbbe","orcid":"https://orcid.org/0000-0002-8550-1407","observed_orcids":["https://orcid.org/0000-0002-8550-1407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristina L\u00fcbbe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114004980","display_name":"Petra Krabisch","orcid":"https://orcid.org/0009-0001-1433-2693","observed_orcids":["https://orcid.org/0009-0001-1433-2693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petra Krabisch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049585448","display_name":"Arndt Hartmann","orcid":"https://orcid.org/0000-0002-4860-4626","observed_orcids":["https://orcid.org/0000-0002-4860-4626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arndt Hartmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109713089","display_name":"Philip R\u00e4th","orcid":"https://orcid.org/0009-0009-6715-6337","observed_orcids":["https://orcid.org/0009-0009-6715-6337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Raeth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003887595","display_name":"Sabine Kasimir\u2010Bauer","orcid":"https://orcid.org/0000-0002-8081-1799","observed_orcids":["https://orcid.org/0000-0002-8081-1799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Kasimir-Bauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021298305","display_name":"Hans\u2010Christian Kolberg","orcid":"https://orcid.org/0000-0003-0221-3272","observed_orcids":["https://orcid.org/0000-0003-0221-3272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans-Christian Kolberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"P2","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9210000038146973},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7549999952316284},{"id":"https://openalex.org/keywords/low-tumor-burden","display_name":"low tumor burden","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7639999985694885},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.45899999141693115},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6449999809265137},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.546999990940094},{"id":"https://openalex.org/keywords/node-negative-breast-cancer","display_name":"node-negative breast cancer","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8942221999168396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7960898876190186},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6325451135635376},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5716713070869446},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.503811776638031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4945482909679413},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4662341773509979},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.44295981526374817},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.39903610944747925},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.1342771351337433}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-p2-11-17","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p2-11-17","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414152947","https://openalex.org/W4411288648","https://openalex.org/W4396587266","https://openalex.org/W4322775344","https://openalex.org/W3166245748","https://openalex.org/W4221031788","https://openalex.org/W4379329491","https://openalex.org/W3010020169","https://openalex.org/W4246797495","https://openalex.org/W7065726135"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Neoadjuvant":[2,287],"chemotherapy":[3,47,62,107,490,546,565],"in":[4,16,63,70,152,158,165,173,179,184,256,289,301,315,371,376,381,412,417,437,442,561,586,635,647],"combination":[5,334,636],"with":[6,38,46,80,114,198,236,247,358,397,466,481,488,588],"an":[7,85,320,492,559],"immune":[8,143,284,493,514,644],"checkpoint":[9,494],"inhibitor":[10],"(ICI)":[11],"is":[12,69,83,218,474],"standard":[13],"of":[14,18,56,61,76,96,120,141,230,271,294,324,333,555,558,580,672],"care":[15],"cases":[17],"high-risk":[19],"(tumor":[20],"size":[21],"\u2265":[22,406],"2":[23,41,209,221,362],"cm":[24,42,210,363],"and/or":[25],"N+)":[26],"early":[27,115,650],"triple":[28,651],"negative":[29,36,78,176,366,427,431,652],"breast":[30,653],"cancer":[31,654],"(eTNBC).":[32,117],"In":[33,49,350,444],"contrast,":[34],"node":[35,77,365],"patients":[37,79,113,197,357,396,480,508,587,648],"tumors":[39,82,206,359,400,428],"<":[40,242],"are":[43],"currently":[44],"treated":[45,487],"alone.":[48],"fact,":[50],"based":[51],"on":[52,283],"a":[53,97,192,219,228,545,553,642],"large":[54],"series":[55],"real-world":[57],"data":[58,662],"the":[59,73,94,121,134,142,153,159,166,174,272,475,513,523,539,556,572,577,664,673],"benefit":[60,511,554],"TNBC":[64,116,238],"smaller":[65,207,360,533],"than":[66,361],"10":[67],"mm":[68],"question.":[71,87],"Overall,":[72],"optimal":[74],"management":[75],"T1c":[81],"still":[84],"unanswered":[86],"The":[88,118,336,420],"neoMono":[89,337,540,667],"trial":[90,135,224,541,668],"prospectively":[91],"analyzed":[92],"whether":[93],"addition":[95,302,557],"preceding":[98],"Atezolizumab":[99,104,295,321,634],"monotherapy":[100,322],"window":[101,145,323,646],"prior":[102,330,345],"to":[103,226,263,303,331,522,532,563,574],"and":[105,163,182,200,214,233,244,254,277,347,364,374,386,415,440,454,483,491,584,590],"neoadjuvant":[106,304,489,564,582,666],"(CTX)":[108],"improves":[109],"pCR":[110,147,150,408,422,517],"rates":[111,151,409,423,518],"among":[112],"results":[119],"primary":[122,237],"endpoint":[123],"analysis":[124,194,353,446,473],"have":[125],"been":[126],"reported":[127],"last":[128],"year":[129],"at":[130],"this":[131,351,382],"meeting.":[132],"While":[133],"did":[136,542],"not":[137,543],"demonstrate":[138],"significant":[139,497],"superiority":[140],"therapy":[144,448,515,645],"regarding":[146,479,552],"rates,":[148],"impressive":[149],"PD-L1":[154,175,260,274,281,398,425,450,457,506],"positive":[155,403,507],"population":[156,177,526],"(91.5%":[157],"experimental":[160],"arm":[161,168,180,185,316,372,377,413,418,438],"A":[162,181,317,373,414,439],"82.2%":[164],"control":[167],"B)":[169,186],"as":[170,172,205,240,405,433],"well":[171],"(56.1%":[178],"64.5%":[183],"were":[187,379,389,410,435,499,519],"observed.":[188],"Here":[189],"we":[190,354],"present":[191],"subgroup":[193,352,383],"including":[195],"only":[196,356,456,547],"eTNBC":[199,482,589],"low":[201,484,591,657],"tumor":[202,248,485,534,592,658],"burden":[203,486,659],"(defined":[204,239],"<=":[208],"(i.":[211],"e.":[212],"cT1c)":[213],"cN0).":[215],"Methods:":[216],"NeoMono":[217],"phase":[220],"randomized":[222,665],"multicenter":[223],"planned":[225],"recruit":[227],"maximum":[229],"458":[231],"female":[232],"male":[234],"pts":[235,370],"ER/PR":[241],"10%":[243],"HER2":[245],"negative)":[246],"stages":[249],"cT1c":[250],"\u2013":[251,660],"cT4d":[252],"(cN0":[253],"cN+)":[255],"34":[257],"study":[258,291,393,525],"sites.":[259],"status":[261,459],"had":[262],"be":[264,529,567],"identifiable":[265],"by":[266,269,280,311,319],"central":[267],"pathology":[268],"means":[270],"VENTANA":[273],"(SP142)":[275],"assay":[276],"was":[278],"defined":[279,404,432],"expression":[282],"cells":[285],"(IC).":[286],"treatment":[288,502],"both":[290,392],"arms":[292,503],"consisted":[293],"1200":[296],"mg":[297,326],"every":[298],"3":[299,453],"weeks":[300,329],"CTX":[305],"(12":[306],"x":[307],"Carboplatin/Paclitaxel":[308],"q1w":[309],"followed":[310],"4x":[312],"Epirubicin/Cyclophosphamide":[313],"q3w),":[314],"preceded":[318],"840":[325],"once":[327],"two":[328],"initiation":[332],"therapy.":[335],"statistical":[338],"design":[339],"uses":[340],"Bayesian":[341],"posterior":[342],"probabilities":[343],"(uniform":[344],"distribution)":[346],"logistic":[348],"regression.":[349],"included":[355,380],"disease.":[367],"Results:":[368],"57":[369],"51":[375],"B":[378],"analysis.":[384],"Demographics":[385],"baseline":[387],"characteristics":[388],"balanced":[390],"between":[391,501],"arms.":[394],"Among":[395],"(IC)":[399,402,426,430,458],"(PD-L1":[401,429],"1%)":[407],"100%":[411],"90%":[416],"B.":[419],"corresponding":[421],"for":[424],"<1%)":[434],"65.9%":[436],"76.3%":[441],"arm.":[443],"multivariate":[445],"(including":[447],"arm,":[449,548],"status,":[451],"grade":[452],"age)":[455],"(OR":[460],"8.46;":[461],"p":[462],"<0.044)":[463],"interacted":[464],"significantly":[465],"pCR.":[467],"Conclusion:":[468],"To":[469],"our":[470,472],"knowledge":[471],"largest":[476],"prospective":[477,661],"dataset":[478],"inhibitor.":[495],"No":[496],"differences":[498],"seen":[500],"although":[504],"numerically":[505],"showed":[509],"increased":[510],"from":[512,663],"window.":[516],"higher":[520],"compared":[521],"overall":[524],"which":[527],"may":[528],"attributed":[530],"particularly":[531],"size.":[535],"We":[536],"acknowledge":[537],"that":[538],"include":[544],"therefore,":[549],"no":[550],"conclusions":[551],"ICI":[560],"general":[562],"can":[566],"drawn.":[568],"Our":[569],"result":[570],"underscore":[571],"need":[573],"further":[575],"evaluate":[576],"clinical":[578],"efficacy":[579],"combined":[581],"chemo-":[583],"ICI-therapy":[585],"burden.":[593],"Citation":[594],"Format:":[595],"Cornelia":[596],"Kolberg-Liedtke,":[597],"Johannes":[598],"Schumacher,":[599],"Ramona":[600],"Erber,":[601],"Michael":[602,611],"Braun,":[603],"Peter":[604],"A.":[605],"Fasching,":[606],"Eva-Maria":[607],"Grischke,":[608],"Christian":[609],"Schem,":[610],"P.":[612],"Lux,":[613],"Mustafa":[614],"Deryal,":[615],"Oliver":[616],"Hoffmann,":[617],"Bernhard":[618],"Heinrich,":[619],"Georg":[620],"Kunz,":[621],"Kristina":[622],"L\u00fcbbe,":[623],"Petra":[624],"Krabisch,":[625],"Arndt":[626],"Hartmann,":[627],"Philip":[628],"Raeth,":[629],"Sabine":[630],"Kasimir-Bauer,":[631],"Hans-Christian":[632],"Kolberg.":[633],"w/":[637,639,649],"polychemotherapy":[638],"or":[640],"without":[641],"pretherapeutic":[643],"(eTNBC)":[655],"&":[656],"[abstract].":[669],"In:":[670],"Proceedings":[671],"San":[674,683],"Antonio":[675],"Breast":[676],"Cancer":[677,690],"Symposium":[678],"2024;":[679],"2024":[680],"Dec":[681],"10-13;":[682],"Antonio,":[684],"TX.":[685],"Philadelphia":[686],"(PA):":[687],"AACR;":[688],"Clin":[689],"Res":[691],"2025;31(12":[692],"Suppl):Abstract":[693],"nr":[694],"P2-11-17.":[695]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}